Oklahoma Heart Hospital now offers a new treatment option for patients with persistent atrial fibrillation (AFib) . In fall 2020, the FDA approved the Thermocool Smarttouch Catheter for use in AFib patients. This new treatment offers better long-term results for those with persistent atrial fibrillation.